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Abstract
Introduction. Blood loss and bile leakage are well-known risk factors for morbidity and mortality during liver resection.
Bleeding usually occurs during parenchymal transection, and surgical technique should be considered an important factor
in preventing intraoperative and postoperative complications. Objective. Many approaches and devices have been developed
to limit bleeding and bile leakage. The aim of the present study was to determine whether a bipolar vessel sealing device
allows a safe and careful liver transection without routine inflow occlusion, achieving a satisfactory hemostasis and
bile stasis, thus reducing blood loss and bile leak and related complications. Patients and methods. A total of 50 consecutive
patients (24 males, 26 females, with a mean age of 57 years) underwent major and minor hepatic resections using a bipolar
vessel sealing device. A clamp crushing technique followed by energy application was used to perform the parenchymal
transection. Inflow occlusion was used when necessary to control blood loss but not as a routine. No other devices were
applied to achieve hemostasis. Results. The instrument was effective in 45 patients and failed to achieve hemostasis in 5
cases, all of whom had a cirrhotic liver. Median blood loss was 490 ml (range 1002500 ml) and intraoperative blood
transfusions were required in eight cases (16%). Mean operative time was 178 min (range 50315 min). Inflow occlusion
was necessary in 16 (32%) patients. The postoperative complication rate was 24%, with a postoperative hemorrhage in a
cirrhotic patient. There was no clinical evidence of bile leak or procedure-related abdominal abscess. Conclusion. We
conclude that the device is a useful tool in standard liver resection, achieving good hemostasis and bile stasis in patients with
normal liver parenchyma, but its use should be avoided in cirrhotic patients.
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Introduction
Despite standardized techniques for liver resections,
at high volume centers, partial hepatectomy has been
reported to yield morbidity rates of 2346%, and
surgical death rates ranging from 4% to 5% [13].
Intraoperative blood loss is a powerful determinant of
operative outcome and remains a major concern for
surgeons operating on the liver, with a reported
median blood loss of 7001200 ml. Bleeding repre-
sents the major intraoperative surgical complication,
and together with bile leaks and hepatic failure, is also
one of the major postoperative complications [46].
In fact a high intraoperative blood loss is associated
with the extensive use of vessel occlusion techniques
(directly related to higher risk of postoperative hepatic
failure and ischemic/reperfusion injury of the liver)
and with a high transfusion rate (cause of host
immunosuppression with more perioperative infec-
tions and shorter long-term survival for early recur-
rence of malignancies in neoplastic patients) [710].
Most blood loss during liver resection occurs during
parenchymal transection. Multiple approaches have
therefore evolved to reduce hemorrhage in this phase
of the procedure. Four main types of strategies have
been developed: a) limit blood flow through the liver
by prophylactic vessel occlusion (improved by tech-
niques of intermittent inflow occlusion and Clavien’s
preconditioning) [1113]; b) reduce central venous
pressure during the transection phase of the interven-
tion [14]; c) perform anatomical limited resections
based on the preoperative evaluation and on intrao-
perative ultrasonography (IOUS); and d) prevent
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blood loss along the plane of transection during
parenchymal division. Several techniques have been
developed for safe and careful dissection of parench-
yma. In addition to blunt dissection using the ‘finger
fracture’ and the clamp crushing techniques various
device have been developed. On one hand there are
those that dissect but are not able to achieve hemos-
tasis such as CUSA and the water jet scalpel. On the
other hand are various devices that can directly reduce
blood loss: they are unipolar or bipolar cautery,
harmonic scalpel, stapling devices, laser systems,
microwave tissue coagulation, and the floating ball
system developed by Tissuelink. With these techni-
ques, resection has become quite safe and major blood
loss is uncommon. Because none of these devices can
achieve complete hemostasis during dissection, blood
vessels and biliary tract branches need to be clipped or
sutured. It would be desirable to have a quick and
reliable mean of transecting the parenchyma without
using clips or ligatures, avoiding the routine use of
inflow occlusion. Moreover some of these instruments
have shown a higher incidence of bile leakage com-
pared with conventional clamp crushing techniques
[15], and it is well known that biliary complications
could lead to life-threatening events, such as sepsis and
liver failure [16]. Resection techniques and devices
that minimize hemorrhage, bile leak, and the removal
of functional parenchyma will prove most useful in the
new era of surgical management of liver disease and
there is still room for improvement.
The purpose of our study was to present our
experience with a bipolar vessel sealing device (Liga-
Sure Valleylab Inc., Boulder, CO, USA), which has
been shown to permanently occlude blood vessels as
large as 7 mm in diameter by fusing the collagen
matrix in the vessel wall. After experimental and
clinical experience [17] we applied this technique in
50 consecutive patients undergoing liver resection,
and we evaluated the efficacy of hemostasis and bile
stasis and analyzed biochemical and histological tissue
damage effects.
Patients and methods
In this prospective study we gained experience with
the bipolar vessel-sealing device (BVSD) during
hepatic resection in 50 patients. The study was begun
in January 2002 and completed in January 2005. The
terminology for liver anatomy and resection used is
the Brisbane 2000 terminology of the International
Hepato-Pancreato-Biliary Association [18].
The initial steps of the procedure were performed
in a standard fashion, according to the type of
resection being performed. Isolation, occlusion, and
transection of the portal pedicle was performed in
patients undergoing right hepatectomy (segments 5
8) or right trisectionectomy (segments 48). In these
cases the liver was also dissected off the inferior vena
cava, and the right hepatic vein was isolated and
ligated. In patients undergoing bisegmentomies (two
Couinaud segments), segmentectomies (one Coui-
naud segment), or nonanatomical resections, no pre-
liminary dissection of blood vessels was performed.
Inflow occlusion was not routinely used, but was
instituted in the course of transection if blood loss
exceeded 500750 ml, according to age, preoperative
hematocrit values, and cardiac and hemodynamic
status. Low central venous pressure was not used.
The cutting line was marked on the liver surface by
electrocautery and standard electrocoagulation was
applied to a depth of approximately 2 mm from the
liver surface. The underlying liver tissue was then
divided and the vessels up to 56 mm were sealed
using the LigaSure (Figure 1); the vessels over 56
mm in diameter were sutured. Initially the LigaSure
device was also used to achieve isolation of bilio-
vascular pedicles from surrounding soft hepatic tissue.
However, the dimension of the cross-sectional area of
the blade’s instrument is relatively large and blades are
blunt, so bleeding caused by mechanical trauma to
small vessels was quite frequent. Therefore a combi-
nation of clamp crushing method and LigaSure
technique was adopted. A kelly clamp was used for
isolation of bilio-vascular pedicles from surrounding
soft hepatic tissue and for exposure of a portion of
vessel compatible with the size of the BVSD’s clamp;
then the BVSD’s blades were inserted carefully into
the point of application and the power was applied.
Complete isolation of the target vessel is very im-
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Figure 1. Serial changes in levels of serum aspartate aminotransa-
minase (AST), alanine aminotransaminase (ALT), and total bilir-
ubin in the postoperative period.
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portant in order to focus the radiofrequency power on
the vessel wall that should be sealed and to minimize
dispersion of power in surrounding parenchyma,
resulting in poor hemostasis in the cutting surface.
Then the device was released (although several times
a second application of power was used to achieve a
complete hemostasis), and the vessels were cut with
scissors under direct vision. Once the clamp was
removed care was taken to cut within the edges of
the coagulated tissue, considering that the coagulated
line is approximately 23 mm long and slightly
curved. At the conclusion of the resection, the cut
surface of the liver was explored for bile leaks, which
were sutured if identified. Hemostasis was checked
and eventually achieved if possible with the BVSD
along the bare surface of the liver remnant, or
alternatively with sutures or electrocautery. No other
hemostatic agents or devices were employed.
Results
The LigaSure vessel-sealing system has been used in
50 consecutive hepatic resections. Patients were 24
males and 26 females (median age 57.1 years, range
2577 years). Indications were as follows: 19 meta-
static colorectal cancers, 14 hepatocellular carcinomas
(HCCs), 4 angiomas, 2 metastatic gastric carcinomas,
2 echinococcal cysts, 2 biliary cysts, and 1 each of
metastatic ovarian tumor, metastatic melanoma, me-
tastatic pancreatic carcinoma, metastatic spinocellular
carcinoma, hepatic adenomas, hepatic aspergillosis,
and gallbladder cancer. Patients’ characteristics, in-
dications, and surgical procedures performed are
summarized in Table I. The BVSD was effective in
46 of these procedures (92%), requiring transection
through normal or near-normal hepatic parenchyma.
In four cases of HCC associated with Child-Pugh B
cirrhosis, the device was ineffective in achieving
bloodless parenchymal transection, and the technique
was abandoned because of high blood loss. Hemos-
tasis was achieved with sutures and clips. Inflow
occlusion (Pringle maneuver) was used in 16 (32%)
of these patients; the occlusion never lasted longer
than 40 min (30 min in cirrhotic patients). Intrao-
perative median blood loss was 490 ml (range 100
2500 ml), and intraoperative blood transfusions were
required in 8 patients (16%). Five of these eight
patients had a cirrhotic liver and four required a
change of the technique of resection to control
hemorrhage. Eleven patients were transfused in the
perioperative period; altogether 16 patients (32%)
were transfused, considering as one patient those
transfused both intra- and perioperatively.
When BVSD was ineffective, persistent bleeding
after parenchymal transection was treated using 4/0
polypropylene sutures. Transection of the liver tissue
using the devices was quite rapid in all cases, with the
exception of the cirrhotic livers where the LigaSure
failed in achieving hemostasis. Mean operative time
was 178 min (range 50315 min). Results are shown
in Table II.
Although this is not a comparative study, duration
of surgery does not seem to have been longer than that
reported in the literature for other techniques of
transection [19,20]. There was no clinical evidence
of postoperative bile leaks. Twelve patients (24%)
reported postoperative complications, as follows:
three right pleural effusions (one requiring drainage)
associated with pneumonia, three cases of transient
postoperative hepatic failure, two cases of prolonged
ascites at the drain site without evidencyeof hepatic
insufficiency, one hemoperitoneum that required
Table I. Patients’ characteristics and surgical procedures.
Patients (n  50) No.
Males/females 24/26
Median age (range) 57.1 (2577)
Indications
Colorectal metastases 19
Hepatocellular carcinoma 14
associated with cirrhosis 10
associated with chronic hepatitis 3
Hepatic angioma 4
Echinococcal cysts 2
Metastatic gastric adenocarcinoma 2
Biliary cysts 2
Metastatic spinocellular tumor 1
Metastatic pancreatic adenocarcinoma 1
Metastatic melanoma 1
Metastatic ovarian carcinoma 1
Galbladder cancer 1
Adenoma 1
Hepatic aspergillosis 1
Surgical procedures No.
Right trisectionectomy 1
Left trisectionectomy 1
Right hepatectomy 5
Left hepatectomy 1
Trisegmentectomy 2
Bisegmentectomy 2,3 6
Other bisegmentectomy 12
Segmentectomy 3
Subsegmentectomy 4
Cystopericystectomy 2
Nonanatomical resection 13
Table II. Surgical outcomes.
Parameter Value
Mean operative time (range), minutes 178 (50315)
Intraoperative median blood loss (range), ml 490 (1002500)
Postoperative morbidity (%) 12 (24%)
Postoperative mortality (%) 1 (2.2%)
Intraoperative blood transfusions 8 (16%)
Postoperative blood transfusions 11 (23.9%)
Total transfusion rate 16 (32%)
Patients transfused with 5 2 units of
packed red cells
10
Patients transfused with  2 units of
packed red cells
6
Utilization of Pringle’s maneuver 16 (32%)
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reintervention (a cirrhotic patient with HCC), one
wound infection, one case of intra-abdominal abscess
in a patient already operated for hepatic aspergillosis
(the abscess was percutaneously drained and was a
new localization of the aspergillus), and one pulmon-
ary and cardiac insufficiency.
One patient died because of hemorrhagic intrao-
perative shock after iatrogenic lesion of the right
hepatic vein; in the perioperative period she developed
a thrombosis of the cava vein with a subsequent lethal
hemorrhagic shock. The 30-day mortality was 2% in
this series (1/50).
Postoperative serum levels of aspartate transaminase
(AST), alanine transaminase (ALT), and total bilir-
ubin were monitored as signs of hepatic trauma;
postoperative levels are reported in Figure 1. Figure 2
shows a hematoxylin and eosin (H&E)-stained image
of the transected liver using the BVSD, and demon-
strates the effect on hepatic collagen, bile ducts, and
vessels. From a histologic point of view, at the cut
surface level the parenchyma presents coagulative
necrosis with electrocautery mark for a mean of 1.3
mm in length (range 12 mm) with a gradual reduction
of the thermic damage at about 23 mm from the
central section. The portal areas, including the bile
ductule and artery, demonstrated sclerotic occlusion.
Discussion
Improved techniques for liver resection, better mon-
itoring during anesthesia, and introduction of a
number of technical devices have resulted in reduction
in perioperative morbidity and mortality associated
with blood loss, even though liver surgery still remains
a challenging procedure [21]. Moreover, intraopera-
tive blood loss and the subsequent need for blood
transfusion are considered significant risk factors for
increased complication rates, poor postoperative out-
come, and shorter disease-free survival [22,23]. Also,
intraoperative tissue damage associated with the
technique of parenchymal dissection and the degree
of postoperative injury due the use of inflow occlusion
seem to affect patient outcome [24,25]. Last but not
least biliary leakage is a challenging complication,
occurring in almost 10% of patients undergoing
hepatectomy [26]. For these reasons, technical im-
provements should be considered possible and desir-
able. Furthermore, efforts are currently being made to
prevent the intraoperative blood loss so as to avoid
ischemic damage of the parenchyma due to vascular
occlusion [27]. Our prospective series of hepatic
resections demonstrates, as previously reported
[28,29], that the LigaSure vessel-sealing system is a
safe and effective instrument for transection of liver
parenchyma employing radiofrequency (RF). It is able
to permanently seal hepatic veins and arteries up to
several millimeters in diameter, without additional
devices or clips and knots. RF has already been
demonstrated to be useful in liver disease. Percuta-
neous and intraoperative RF ablation are well known
therapeutic approaches to primary and metastatic liver
cancer and are historically considered alternative or
complementary to surgery. The development of new
techniques and devices has shown that RF-based
surgery can be feasible and useful. In 2002 Habib’s
group [30] described a technique for liver resection
using RF energy (monopolar electrodes) to coagulate
liver resection margins before division of parenchyma
with a surgical scalpel, allowing a quite complete
bloodless liver resection without the use of sutures,
clips, or glue. In 2001 Horgan described first the use of
LigaSure System in liver resection [28] and in 2002
the monopolar floating ball by Tissuelink (TMFB)
was introduced into clinical practice. Both TMFB and
BVSD are able to seal vascular and biliary vessels by
collagen fusion but TMFB is useful for preventive
coagulation of the liver surface that guarantees fusion
of vessels up to 23 mm in diameter, while BVSD can
Figure 2. Specimen histopathology. Histologic images of resection
edge margin demonstrate that the center of the sample is necrotic
with almost total disappearance of parenchyma for about 2.3 mm in
diameter. The parenchyma in immediate proximity presents coa-
gulative necrosis with electrocautery mark for 1.21.6 mm in
length; the portal areas present destruction of the interlobular
vessels (hepatic artery, portal vein, and bile ductule) with sclerotic
occlusion. We observed gradual reduction of the thermic damage at
about 0.20.4 cm from the central section. H&E stain, 250.
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focus RF energy on the vessel enclosed between its
clamps and is able to permanently seal hepatic veins,
arteries, and biliary vessels up to 7 mm in diameter,
preventing bleeding and providing a real and safe
alternative to clips and sutures.
From a histologic point of view one of the advan-
tages shown in our series is the modest tissue trauma
that the BVSD produces and the controlled dissection
of tissue that it allows. The lateral thermal spreading
and conduction, which represents the area of coagula-
tion outside the clamp, extend for a mean of 1.3 mm
(range 12 mm) on either side and are significantly
lower if compared with electrocoagulation, harmonic
scalpel, and laser. Taking into account the known
correlation of the extent of intraoperative tissue
damage, healing complications, and postoperative
septic complications, this can explain the low mor-
bidity rate related to parenchymal damage in our
results. Moreover the involvement of the biliocytes in
the area of complete coagulative necrosis and the
effective occlusion of bile ductules on histologic
analysis demonstrate the rationale of the absence of
postoperative bile leaks, as previously reported with
this device [31]. Intrahepatic biliary radicals smaller
than segmental branches appeared to be well sealed by
the BVSD, and bile leaks were recognized infre-
quently at the end of the transection on the cut
surface of the liver. This is an important goal of the
LigaSure sealing device because bile leaks represent a
frequent and potentially life-threatening postoperative
complication of liver resection, ranging from 4.5% to
11%, particularly considering that other devices such
as the harmonic scalpel seem to be related to an
increased incidence of postoperative bile leaks [32].
This fact could be correlated with a higher capacity of
RF in sealing biliary ducts if compared with ultra-
sonically activated energy. In fact, no bile leaks have
been reported with the MTFB or Habib’s technique
[33,34], or in our experience. It has been reported
that the microwave tissue coagulator method can
induce bile leakage or infection due to necrotic
detachment of the cut margin of the residual liver.
Since the coagulation temperature with the LVSD is
B1008C, tissue damage is minimal. Indeed the
necrotic changes at the cut margin of the residual
liver following surgery with our technique were
minimal, thus reducing complications such as post-
operative bleeding, bile leakage, and abscess forma-
tion [35]. In fact in our series we experienced only one
intra-abdominal abscess, which was not related to the
transection technique, but to the patient’s disease
(recurrence of aspergillosis). Moreover, in our experi-
ence the area of transection is under the direct visual
control of the surgeon, allowing for the identification
of intrahepatic structures. This is an advantage over
some microwave coagulation techniques, which re-
quire an essentially blind tissue coagulation, obviating
the opportunity to identify and coagulate key struc-
tures in a controlled setting, and contributing to the
incidence of hemorrhage and bile leak. Postoperative
serum levels of ALT, AST, and bilirubin were
comparable to data reported in the literature after
liver resection [35,36]. This result of our series
demonstrated that controlled use of RF on the target
vessels of the BVSD reduces hepatic trauma and does
not leave a large amount of necrotic tissue at the cut
surface, thus not resulting in a major sacrifice of
normal parenchyma, as happens with other techni-
ques. The degeneration is limited to the transection
surface and is well correlated with increase of AST/
ALT levels and is different from the whole-liver
ischemic damage caused by inflow occlusion.
Blood transfusions were infrequent in our series with
the BVSD, with 16% of patients transfused intraopera-
tively, a lower rate than in major series reported in the
literature. DeMatteo et al. reported a large series in
which 38% of patients received intraoperative transfu-
sions [37], and Nuzzo et al. reported a 41% rate of
blood transfusions [38] during resections with inflow
occlusion. Many of our patients did not have under-
lying cirrhosis, which may explain the minimal need for
blood replacement during hepatic resection; never-
theless our results seem favorable when compared to
literature reports. One concern about this instrument
remains. In our experience, the BVSD fails to achieve a
satisfactory hemostasis during transection of cirrhotic
parenchyma. Use of this device was abandoned during
liver resection in four cirrhotic patients, because of
uncontrollable blood loss. We believe that the hard
liver parenchyma, as in cirrhotic patients, made the
crushing technique difficult, and the hepatic tissue
between the blades of the devices may have dispersed
the power applied, causing vessels to bleed. LigaSure
works particularly poorly in cirrhotic patients and
seems to be unable to achieve a correct hemostasis,
requiring the use of alternative techniques. We believe
that the limits of the BVSD are not related to the energy
used (RF), but to the shape of the instrument that in
the case of hard parenchyma is not able to ensure good
functioning. In fact several studies report that the
TMFB and the RF techniques are useful in cirrhotic
patients. Operative times do not differ from those
usually reported in similar series. Moreover the sur-
geon can avoid the use of too many metal clips, which
may slip off and may cause rebleeding during subse-
quent manipulation, and the policy of ‘leaving nothing
behind is an attractive strategy. In conclusion the
LigaSure vessel-sealing system seems to be a useful
device for limiting blood loss and postoperative bile
leaks in patients who underwent hepatic surgery.
Inflow occlusion and blood transfusion are needed
infrequently when using this tool and it does not
appear to contribute to abscess formation. Otherwise
it is cumbersome in cirrhotic livers.
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